05B4 Waldman, Scott - Jefferson Medical College - Thomas Jefferson University
saw103

Scott A. Waldman, MD, PhD

Contact Dr. Waldman

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-6086
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. Obesity pharmacotherapy: What is next?
  2. GUCY2C: at the intersection of obesity and cancer
  3. Advancing pharmacometrics and systems pharmacology
  4. Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer
  5. Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer
  6. GUCY2C molecular staging personalizes colorectal cancer patient management
  7. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C
  8. Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes
  9. Molecular staging individualizing cancer management
  10. Clinical pharmacology therapeutics 2011: Year in review
  11. GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity
  12. The Value Proposition of Molecular Medicine
  13. Knowledge cycle transforms therapeutic innovation
  14. GUCY2C-targeted cancer immunotherapy: Past, present and future
  15. Patient-centric clinical pharmacology advances the path to personalized medicine
  16. Cardiovascular health: The global challenge
  17. Widening the path to personalized medicine.
  18. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice
  19. A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer
  20. Clinical pharmacology as a foundation for translational science
0